BioMedical Technology Solutions, Inc. a Division of BioMedical Technology Solutions Holdings, Inc. Symbol (BMTL) OTCBB Receives Frost & Sullivan's Product Innovation of the ...( Expertise and Technology for the Medi...),Health

Expertise and Technology for the Medical Waste Treatment Market

MOUNTAIN VIEW, Calif., April 6 /PRNewswire/ -- Based on its recent analysis of the medical waste treatment market, Frost & Sullivan recognizes BioMedical Technology Solutions (BMTS), Inc. with the 2009 North American Frost & Sullivan Award for Product Innovation of the Year. The company has outpaced its competitors in product innovation, as evidenced by its introduction of the Demolizer(R) II. This novel system provides a simple and effective solution to biomedical waste management at the point of generation, thereby eliminating the possibility of sharps and red bag biomedical waste being disposed of directly into the environment.

(Logo: http://www.newscom.com/cgi-bin/prnh/20081117/FSLOGO)

Most market participants are reluctant to invest in R&D because the market is not considered big enough to warrant huge expenses on product innovation. However, it was established that in 2007, more than 1.5 billion pounds (or 5 pounds per person) of biomedical waste was generated in the U.S. costing over $3.5 billion to remove and destroy. Such statistics, which prompted BMTS to cash in on the market potential, led to the Demolizer(R) II.

Biomedical waste processed with the Demolizer(R) II is rendered sterile and non-biohazardous. The Demolizer(R) II eliminates the need to store waste on site between pickups, removing the possibility of bacterial growth and thereby, airborne diseases.

It simplifies compliance requirements by automatically storing and printing state and local regulatory data after every process. The technology eliminates all legal liabilities (Cradle to Grave) and provides complete control over biomedical waste disposal requirements.

"The Demolizer II is the best method available to manage biomedical wa
'/>"/>